Description / Application
Febuxostat is a 1,3-thiazolemonocarboxylic acid that is 4-methyl-1,3-thiazole-5-carboxylic acid which is substituted by a 3-cyano-4-(2-methylpropoxy)phenyl group at position 2. It is an orally-active, potent, and selective xanthine oxidase inhibitor used for the treatment of chronic hyperuricaemia in patients with gout. It has a role as an EC 1.17.3.2 (xanthine oxidase) inhibitor. It is a nitrile, an aromatic ether and a 1,3-thiazolemonocarboxylic acid.
Identities
| Alternative Name | Adenuric; 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
|---|---|
| Molecular Formula | C16H16N2O3S |
| Molecular Weight | 316.4 |
| MFCD | MFCD00871598 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning! |
| Hazard Statements | H302+H312+H332;H315;H319 |
| Precautionary Statements | P261;P271;P270;P264;P280;P301+P312+P330;P330;P352;P312;P362;P304+P340;P312;P351;P338;P331;P337+P313;P501; |